Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Heart Failure: Treatment

Description: Heart failure (HF) is the inability of the heart to pump a sufficient amount of blood into the blood vessels. Cardiac damage that initiates the vicious cycle of heart failure usually occurs as a result of other cardiac diseases, such coronary artery disease, coronary heart disease, or a disease of one of the valves of the heart. Although heart failure is a disease with devastating effects, the treatment regimens continue to improve as more and more is discovered about the physiological causes of this disease. This course describes the prognosis and available treatments for heart failure.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS
4. Objectives
5. Transition to Heart Failure
6. Sudden Cardiac Death and Arrhythmias
7. Adrenergic Receptors
8. Adrenergic Receptor Stimulation
9. Effects of Plasma Noradrenaline
10. Signaling Systems
11. Progress Check

TREATMENT
12. Objectives
13. Sodium and Fluid Restriction
14. Exercise, Rest, and Oxygen
15. Managing Underlying Disease
16. Intra-Aortic Balloon Pump (IABP)
17. Ventricular Assist Device (VAD)
18. Total Artificial Heart (TAH)
19. Extracorporeal Membrane Oxygenation (ECMO)
20. Cardiac Transplantation
21. Progress Check

CONCLUSION
22. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Describe the role of chronically elevated sympathetic nervous system activity with increased plasma noradrenaline levels in the development of heart failure
  • Explain the mechanism and consequences of adrenergic receptor activation
  • Describe the cycle of compensatory mechanisms that lead to progression from mild to severe heart failure
  • State the goals of heart failure therapy
  • Identify devices used for invasive cardiac monitoring and assisted circulation
  • Explain why exercise, rest, oxygen supplementation, and dietary and fluid restrictions are beneficial nondrug therapies for heart failure

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy